Literature DB >> 1873584

Optimization of a slow-acting automatic gain control system for use in hearing aids.

B C Moore1, B R Glasberg, M A Stone.   

Abstract

This paper describes experiments evaluating and optimizing an automatic gain control system, called dual front-end AGC (abbreviated as D), intended for use in hearing aids. This system has two purposes: (1) to compensate for variations in the overall level of speech from one situation to another by slowly changing its gain; (2) to protect the user from sudden intense transients without affecting the long-term gain. This is achieved by using two control voltages to determine the gain. One changes slowly as the input varies in level. Normally this component determines the overall gain. The other comes into operation when an intense transient occurs. It acts rapidly to reduce the gain, avoiding over-amplification of the transient, but its action ceases quickly after the end of the transient. We describe four experiments measuring speech intelligibility for subjects with cochlear hearing loss in which we determine optimum values for two of the time constants of the D system, namely the recovery time of the fast component and the attack time of the slow component. The experiments also compare the D system with linear amplification (L) and 'adaptive compression' (A). The results show: (1) for the D system, optimum values are about 80-150 ms for the recovery time of the fast component and 150-325 ms for the attack time of the slow component; (2) in situations where intense transient sounds are present, and there is either no background sound (experiment 1) or continuous speech-shaped noise as a background (experiment 2), the D system gives significantly better performance than the L or A systems. When the background noise is a single voice, reversed in time (experiment 3), the D and L systems give similar performance, and both are markedly superior to the A system; (3) when the level of speech is varied over a range of 30 dB (experiment 4), both D and A systems allow good performance over the whole range of levels. Performance for the L system worsens markedly at the lower levels.

Entities:  

Mesh:

Year:  1991        PMID: 1873584     DOI: 10.3109/03005369109079851

Source DB:  PubMed          Journal:  Br J Audiol        ISSN: 0300-5364


  8 in total

Review 1.  The choice of compression speed in hearing AIDS: theoretical and practical considerations and the role of individual differences.

Authors:  Brian C J Moore
Journal:  Trends Amplif       Date:  2008-06

2.  Acoustic temporal modulation detection and speech perception in cochlear implant listeners.

Authors:  Jong Ho Won; Ward R Drennan; Kaibao Nie; Elyse M Jameyson; Jay T Rubinstein
Journal:  J Acoust Soc Am       Date:  2011-07       Impact factor: 1.840

3.  Theoretical and practical considerations in compression hearing AIDS.

Authors:  F K Kuk
Journal:  Trends Amplif       Date:  1996-03

4.  Curriculum for graduate courses in amplification.

Authors:  C V Palmer
Journal:  Trends Amplif       Date:  1998-03

5.  Design and evaluation of a cochlear implant strategy based on a "Phantom" channel.

Authors:  Waldo Nogueira; Leonid M Litvak; Aniket A Saoji; Andreas Büchner
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

6.  Can Dual Compression Offer Better Mandarin Speech Intelligibility and Sound Quality Than Fast-Acting Compression?

Authors:  Yuan Chen; Lena L N Wong; Volker Kuehnel; Jinyu Qian; Solveig Christina Voss; Wang Shangqiguo
Journal:  Trends Hear       Date:  2021 Jan-Dec       Impact factor: 3.293

7.  Listening to Music Through Hearing Aids: Potential Lessons for Cochlear Implants.

Authors:  Brian C J Moore
Journal:  Trends Hear       Date:  2022 Jan-Dec       Impact factor: 3.496

8.  Transient Noise Reduction Using a Deep Recurrent Neural Network: Effects on Subjective Speech Intelligibility and Listening Comfort.

Authors:  Mahmoud Keshavarzi; Tobias Reichenbach; Brian C J Moore
Journal:  Trends Hear       Date:  2021 Jan-Dec       Impact factor: 3.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.